Key statistics
On Thursday, Theravance Biopharma Inc (0TB:STU) closed at 9.10, -14.95% below its 52-week high of 10.70, set on Jan 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.35 |
---|---|
High | 9.35 |
Low | 9.05 |
Bid | 9.05 |
Offer | 9.30 |
Previous close | 9.35 |
Average volume | 266.67 |
---|---|
Shares outstanding | 48.92m |
Free float | 46.01m |
P/E (TTM) | -- |
Market cap | 470.14m USD |
EPS (TTM) | -1.01 USD |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Press releases
- Theravance Biopharma to Participate in an Upcoming Investor Conference
- Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value
- Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024
- Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease